HOME >> BIOLOGY >> NEWS
Handicapping tuberculosis may be the way to a better vaccine

Howard Hughes Medical Institute investigator William R. Jacobs and colleagues have produced a genetically altered strain of tuberculosis (TB) that elicits a stronger immune response than the current vaccine, bacillus Calmette-Gurin (BCG). The new vaccine improves survival of infected animals and may help put scientists on track to replace BCG, which has been used for nearly a century although it is largely ineffective.

Despite widespread vaccination programs, the World Health Organization estimates that approximately 2 billion people worldwide are infected with TB, with over 95 percent of infections occurring in developing countries. Most TB is latent, but can become active when the immune system is weak, such as during HIV infection, and more than 1.6 million die each year from this disease. In addition, resistance to current treatments is becoming increasingly common, making an effective vaccine all the more crucial.

Were very excited because this is the first vaccine strain weve ever seen that is significantly better than BCG, said Jacobs.

Jacobs worked in collaboration with Steven Porcelli at the Albert Einstein College of Medicine. The team will publish its findings in the August, 2007, issue of the Journal of Clinical Investigation.

The immune system has a very difficult time detecting and combating Mycobacterium tuberculosis, the bacteria responsible for tuberculosis. By creating a strain of TB that behaves differently, Jacobs believes he can build a vaccine that prepares the body to recognize TB when infected.

If a cell becomes aware that a pathogen has invaded, it can prevent the infection from spreading to other cells by committing cell suicidea process known as apoptosis, where the cell shuts down and is shredded into little pieces.

Immune system cells further chop up these cellular bits and present them to white blood cells called T lymphocytes. Each T lymphocyte specifically recognizes a different sma
'"/>

Contact: Jennifer Michalowski
michalow@hhmi.org
301-215-8576
Howard Hughes Medical Institute
1-Aug-2007


Page: 1 2 3

Related biology news :

1. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
2. Developing a more effective vaccine for tuberculosis
3. Why is long-term therapy required to cure tuberculosis?
4. UA researchers identify new adherence factor, Pili, produced by tuberculosis
5. Shorter tuberculosis therapies could lead to substantial reductions in cases and deaths
6. Pitt phage hunter takes on tuberculosis
7. Cost-effectiveness of treating multidrug-resistant tuberculosis
8. New potential drug target in tuberculosis
9. National Institutes of Health funds $13.7 million for Texas tuberculosis study
10. Einstein researchers find potential new drugs for tuberculosis
11. Studies suggest new targets for tuberculosis treatments

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):
(Date:5/15/2017)... ... May 15, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it has signed an agreement ... support preclinical and clinical development of TA-46, a novel protein addressing achondroplasia, which ...
(Date:5/15/2017)... ... May 15, 2017 , ... Continuing to build off ... has today launched its first-ever cross-medium campaign, #StandFirm, with high-visibility social and digital ... social media channels, emphasizing Algenist’s stance on individuality and disruption: , We ...
(Date:5/12/2017)... ANN ARBOR, Mich. , May 12, 2017 /PRNewswire/ ... been selected to present at the 36th annual Michigan ... Investment Forum. GreenMark, a Delaware ... will be presenting to investors in attendance, including more ... to deliver health benefits to society through biobased targeting ...
(Date:5/11/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), a ... and tissue hypothermic storage and cryopreservation freeze ... and financial results for the first quarter of 2017. ... high of $2.4 million in the first quarter of 2017, ... Revenue growth was driven by sales of CryoStor ® ...
Breaking Biology Technology:
Cached News: